Ginkgo Bioworks teams up with CMU for cancer screening, gets ARPA-H award for POSEIDON program. NYSE: DNA.

Unusual Whales
2025.12.22 18:23
In Boston on December 22, 2025, Ginkgo Bioworks revealed a collaboration with Carnegie-Mellon University, receiving an award from the Advanced Research Projects Agency for Health (ARPA-H) for their POSEIDON program. The partnership with CMU focuses on the Platform Optimizing SynBio for Early Intervention initiative. Ginkgo Bioworks is listed on NYSE as DNA.
Source: Unusual Whales The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
© 2025 Longbridge｜Disclaimer